The trouble with dabigatran

被引：22

作者：

Charlton, Blake ^{[1
]}

Redberg, Rita ^{[1
]}

机构：

[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2014年 / 349卷

关键词：

ATRIAL-FIBRILLATION; STROKE; RISK;

D O I：

10.1136/bmj.g4681

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 10 条

[1] ANTICOAGULANTS Dabigatran: how the drug company withheld important analyses
Cohen, Deborah
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[2] Newly Identified Events in the RE-LY Trial
Connolly, Stuart J.
Ezekowitz, Michael D.
Yusuf, Salim
Reilly, Paul A.
Wallentin, Lars
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19) : 1875 - 1876
[3] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Connolly, Stuart J.
Ezekowitz, Michael D.
Yusuf, Salim
Eikelboom, John
Oldgren, Jonas
Parekh, Amit
Pogue, Janice
Reilly, Paul A.
Themeles, Ellison
Varrone, Jeanne
Wang, Susan
Alings, Marco
Xavier, Denis
Zhu, Jun
Diaz, Rafael
Lewis, Basil S.
Darius, Harald
Diener, Hans-Christoph
Joyner, Campbell D.
Wallentin, Lars
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151
[4] Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score
Lip, Gregory Y. H.
Frison, Lars
Halperin, Jonathan L.
Lane, Deirdre A.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (02) : 173 - 180
[5] Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Lip, Gregory Y. H.
Nieuwlaat, Robby
Pisters, Ron
Lane, Deirdre A.
Crijns, Harry J. G. M.
[J]. CHEST, 2010, 137 (02) : 263 - 272
[6] Dabigatran, bleeding, and the regulators
Moore, Thomas J.
Cohen, Michael R.
Mattison, Donald R.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[7] The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)
Reilly, Paul A.
Lehr, Thorsten
Haertter, Sebastian
Connolly, Stuart J.
Yusuf, Salim
Eikelboom, John W.
Ezekowitz, Michael D.
Nehmiz, Gerhard
Wang, Susan
Wallentin, Lars
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (04) : 321 - 328
[8] A Comparison of Results of the US Food and Drug Administration's Mini-Sentinel Program With Randomized Clinical Trials: The Case of Gastrointestinal Tract Bleeding With Dabigatran
Sipahi, Ilke
Celik, Seden
Tozun, Nurdan
[J]. JAMA INTERNAL MEDICINE, 2014, 174 (01) : 150 - 151
[9] Thomas Katie., 2014, The New York Times
[10] U.S. Food and Drug Administration, 2011, PRAD DAB ET MES DRUG

← 1 →